We are live on
!
Find out more
CF
Corebridge Financial Portfolio holdings
AUM
$4.25M
1-Year Est. Return
33.15%
This Fund
S&P 500
This Quarter
Est. Return
+4.01%
1 Year Est. Return
-33.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.2B
AUM Growth
–
Cap. Flow
+$17.7B
Cap. Flow
% of AUM
97.06%
Top 10 Holdings %
Top 10 Hldgs %
26.4%
Holding
3,057
New
3,055
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$936M |
| 2 |
Apple
AAPL
|
+$762M |
| 3 |
NVIDIA
NVDA
|
+$739M |
| 4 |
Amazon
AMZN
|
+$480M |
| 5 |
Meta Platforms (Facebook)
META
|
+$317M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.31% |
| 2 | Financials | 12.14% |
| 3 | Healthcare | 11.33% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 10.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Newell Brands
NWL
$2.49B
| $123K | ﹤0.01% |
+19,254
| New | +$143K |
|
2477
Hyliion Holdings
HYLN
$697M
| $123K | ﹤0.01% |
+75,820
| New | +$113K |
|
|
MRSN
2478
DELISTED
Mersana Therapeutics
MRSN
| $123K | ﹤0.01% |
+2,441
| New | +$176K |
|
2479
Omeros
OMER
$1.32B
| $122K | ﹤0.01% |
+30,092
| New | +$108K |
|
2480
Red River Bancshares
RRBI
$681M
| $122K | ﹤0.01% |
+2,544
| New | +$119K |
|
2481
Telos
TLS
$295M
| $122K | ﹤0.01% |
+30,272
| New | +$115K |
|
2482
Utah Medical Products
UTMD
$222M
| $122K | ﹤0.01% |
+1,822
| New | +$124K |
|
|
SSBK
2483
DELISTED
Southern States Bancshares
SSBK
| $122K | ﹤0.01% |
+4,483
| New | +$114K |
|
2484
Southern First Bancshares
SFST
$598M
| $121K | ﹤0.01% |
+4,153
| New | +$114K |
|
2485
TScan Therapeutics
TCRX
$21.7M
| $121K | ﹤0.01% |
+20,658
| New | +$163K |
|
2486
Viemed Healthcare
VMD
$335M
| $121K | ﹤0.01% |
+18,450
| New | +$139K |
|
2487
TransUnion
TRU
$14.9B
| $121K | ﹤0.01% |
+1,626
| New | +$121K |
|
2488
KE Holdings
BEKE
$18.7B
| $120K | ﹤0.01% |
+8,500
| New | +$133K |
|
2489
Nektar Therapeutics
NKTR
$2.38B
| $120K | ﹤0.01% |
+6,403
| New | +$135K |
|
2490
Actinium Pharmaceuticals
ATNM
$44M
| $120K | ﹤0.01% |
+16,174
| New | +$133K |
|
2491
Park-Ohio Holdings
PKOH
$673M
| $120K | ﹤0.01% |
+4,619
| New | +$117K |
|
2492
Mama's Creations
MAMA
$694M
| $120K | ﹤0.01% |
+17,705
| New | +$108K |
|
2493
ADC Therapeutics
ADCT
$137M
| $119K | ﹤0.01% |
+37,666
| New | +$150K |
|
2494
Custom Truck One Source
CTOS
$2.07B
| $119K | ﹤0.01% |
+27,445
| New | +$134K |
|
|
PBPB
2495
DELISTED
Potbelly
PBPB
| $119K | ﹤0.01% |
+14,769
| New | +$137K |
|
2496
Northeast Community Bancorp
NECB
$369M
| $118K | ﹤0.01% |
+6,626
| New | +$109K |
|
2497
First Internet Bancorp
INBK
$245M
| $118K | ﹤0.01% |
+4,368
| New | +$132K |
|
2498
Microvision
MVIS
$50.2M
| $118K | ﹤0.01% |
+7,400
| New | +$146K |
|
2499
John Marshall Bancorp
JMSB
$325M
| $117K | ﹤0.01% |
+6,737
| New | +$114K |
|
2500
GitLab
GTLB
$7.83B
| $117K | ﹤0.01% |
+2,357
| New | +$122K |
|
Similar funds
WH
PS
CGA
EAMS
OFC
FM
BP
GFM
Corebridge Financial's Q2 2024 Portfolio in Review
Q2 2024 is the first quarter with a 13F filing on record for Corebridge Financial, which disclosed 3,057 positions worth $18.2B. Its ten largest holdings account for 26% of the portfolio.
Its largest position is Microsoft: 2,215,349 shares worth $990M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, followed by Financials and Healthcare.
- Corebridge Financial's largest Q2 2024 buy was Microsoft: 2,215,349 shares worth $990M.
- Corebridge Financial's ten largest holdings make up 26% of its $18.2B portfolio in Q2 2024.
- Corebridge Financial disclosed 3,057 positions in Q2 2024, its first 13F filing on record.
Based on Corebridge Financial's 13F filing for Q2 2024, filed 14 Aug 2024.